top of page
.jpeg)
Arie Regev, MD, FAASLD
Gastroenterologist and hepatologist with more than 30 years of clinical, academic, and pharmaceutical leadership experience.
-
Retired Vice President of Global Patient Safety at Eli Lilly
-
Founding co-chair of IQ DILI
-
Former Associate Professor of Medicine at the Division of Hepatology, University of Miami and the Division of Gastroenterology and Hepatology, Indiana University School of Medicine
-
Author of more than 150 publications and chapters in major scientific journals and books

Hepatology and Liver Safety Consulting, LLC provides expert hepatic safety and drug-induced liver injury (DILI) consulting to pharmaceutical and biotechnology companies throughout the drug development lifecycle, from preclinical research through post-marketing surveillance.
Founding co-chair of the IQ-DILI Initiative and co-chair of its Immunotherapy, Gene Therapy, and Pediatrics working groups.

bottom of page
